Xiangxue Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Xiangxue Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Xiangxue Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Held to maturity investment70,000,0000.0061282015-06-30historic
Net change in cash1,388,901,7930.12102462015-06-30historic
Net cashflow from financing activities1,459,853,8020.1272882015-06-30historic
Goodwill422,528,2330.036821122015-06-30historic
Interests payable26,588,1250.002322172015-06-30historic
Net cash and cash equivalents ending balance1,683,745,6580.146712312015-06-30historic
Comprehensive income attributable to minority shareholders10,023,1038.7E-42502015-06-30historic
Minority interests gain10,023,1038.7E-42522015-06-30historic
Diluted eps00.02602015-06-30historic
Capital reserve2,137,981,7630.186292682015-06-30historic
Interest receivable1,669,1301.5E-42822015-06-30historic
Cash inflows from financing activities1,999,653,5400.174243032015-06-30historic
Selling expenses96,894,6370.008444332015-06-30historic
Non-operating loss1,714,6401.5E-44662015-06-30historic
Minority interest132,561,1400.011554692015-06-30historic
Financial expenses32,073,0400.002794792015-06-30historic
Purchases of fixed assets and others126,695,2790.011044822015-06-30historic
Proceeds from sell of investment10,000,0008.7E-44832015-06-30historic
Notes receivable87,810,3650.007654982015-06-30historic
Other payables139,058,8160.012125322015-06-30historic
Short term borrowings552,000,0000.04815382015-06-30historic
Cash paid for dividends, profits or interests89,799,7380.007825442015-06-30historic
Fixed assets1,204,515,5910.104955472015-06-30historic
Prepayment119,427,6570.010415522015-06-30historic
Long term equity investment52,818,3860.00465602015-06-30historic
Total non-current assets2,414,659,0400.21046012015-06-30historic
Net income103,093,6900.008986082015-06-30historic
Total comprehensive income103,193,9640.008996182015-06-30historic
Operating profit106,969,0670.009326212015-06-30historic
Intangible assets180,753,9840.015756472015-06-30historic
Refunds of taxes1,758,3481.5E-46502015-06-30historic
Total profit110,861,5680.009666552015-06-30historic
Net cash flows from investing activities-119,345,917-0.01047002015-06-30historic
Total liabilities and equity5,087,490,2060.443297072015-06-30historic
Total liabilities1,629,004,9770.141947682015-06-30historic
Other receivables34,781,6950.003037752015-06-30historic
Cash paid for taxes65,468,9960.00578132015-06-30historic
Revenue752,177,7450.065549052015-06-30historic
Total cost of goods sold651,626,4560.056789102015-06-30historic
Cash inflows from operating activities779,679,3950.067949122015-06-30historic
Other current assets7,052,4976.1E-49192015-06-30historic
Inventories309,746,7470.026999222015-06-30historic
Cash outflows from operating activities731,286,6080.063729322015-06-30historic
Payroll payable9,223,7998.0E-410152015-06-30historic
Deferred tax assets8,058,7427.0E-410292015-06-30historic
Accounts payable130,459,1960.0113710392015-06-30historic